Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)

Polycystic ovary syndrome (PCOS) is the most frequent cause of female infertility. The treatment of PCOS patients with insulin sensitizers, such as metformin or thiazolidinediones, increases the ovulation rate and the number of successful pregnancies. The positive action of the insulin-sensitizing t...

Full description

Saved in:
Bibliographic Details
Main Authors: Pascal Froment, Philippe Touraine
Format: Article
Language:English
Published: Wiley 2006-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/PPAR/2006/73986
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551589452185600
author Pascal Froment
Philippe Touraine
author_facet Pascal Froment
Philippe Touraine
author_sort Pascal Froment
collection DOAJ
description Polycystic ovary syndrome (PCOS) is the most frequent cause of female infertility. The treatment of PCOS patients with insulin sensitizers, such as metformin or thiazolidinediones, increases the ovulation rate and the number of successful pregnancies. The positive action of the insulin-sensitizing treatments could be explained by a decrease in the peripheral insulin resistance but also by a direct action at the ovarian level. We report in this review different hypotheses of thiazolidinediones actions to improve PCOS (steroid secretion by ovarian cells ; insulin sensitivity in muscle and adipocyte and fat redistribution).
format Article
id doaj-art-19dff30c10464ad6b075163dcc212ab0
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2006-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-19dff30c10464ad6b075163dcc212ab02025-02-03T06:01:05ZengWileyPPAR Research1687-47571687-47652006-01-01200610.1155/PPAR/2006/7398673986Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)Pascal Froment0Philippe Touraine1INSERM Unité 418, UMR Communications Cellulaire et Différenciation, Hôpital Debrousse, 29 Rue Soeur Bouvier, Lyon 69322, FranceDepartment of Endocrinology and Reproductive Medicine, GH Pitié-Salpêtrière, 47‐83 Boulevard de l'Hôpital, Paris Cedex 13 75651, FrancePolycystic ovary syndrome (PCOS) is the most frequent cause of female infertility. The treatment of PCOS patients with insulin sensitizers, such as metformin or thiazolidinediones, increases the ovulation rate and the number of successful pregnancies. The positive action of the insulin-sensitizing treatments could be explained by a decrease in the peripheral insulin resistance but also by a direct action at the ovarian level. We report in this review different hypotheses of thiazolidinediones actions to improve PCOS (steroid secretion by ovarian cells ; insulin sensitivity in muscle and adipocyte and fat redistribution).http://dx.doi.org/10.1155/PPAR/2006/73986
spellingShingle Pascal Froment
Philippe Touraine
Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
PPAR Research
title Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
title_full Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
title_fullStr Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
title_full_unstemmed Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
title_short Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
title_sort thiazolidinediones and fertility in polycystic ovary syndrome pcos
url http://dx.doi.org/10.1155/PPAR/2006/73986
work_keys_str_mv AT pascalfroment thiazolidinedionesandfertilityinpolycysticovarysyndromepcos
AT philippetouraine thiazolidinedionesandfertilityinpolycysticovarysyndromepcos